Pharmaceutical group Nippon Shinyaku reportedly enters the final phase of clinical testing on what could become the first drug in Japan to be approved for the treatment of alcoholism.
MarketWatch.com - Top Stories, MarketWatch
Mon, 08/10/2009 - 10:56pm
Pharmaceutical group Nippon Shinyaku reportedly enters the final phase of clinical testing on what could become the first drug in Japan to be approved for the treatment of alcoholism.